Header Logo

Connection

AYA ALBITTAR to Lymphoma, B-Cell

Back to Details
This is a "connection" page, showing publications AYA ALBITTAR has written about Lymphoma, B-Cell.
AYA ALBITTAR
Connection Strength
0.195
Lymphoma, B-Cell
  1. Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL. Blood Adv. 2023 11 28; 7(22):6990-7005.
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.